Scroll To Top
Search by Speciality


China National Convention Center (CNCC) * | Beijing, CHINA
From 1600 to 3200 RMB
Event Preview
This event
is Finished
Specialty: , Cardiology
Dates: From Apr, 20, 2013 to Apr, 23, 2013
Location: Beijing, CHINA
Type: Congress
Registration Cost: From 1600 to 3200 RMB
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Beijing, China.
General Info
Event Venue:

China National Convention Center (CNCC) *

Beijing, CHINA Visit the Venue to read more


CME Accreditation and Designation The China Interventional Therapeutics is accredited by the Accreditation Council for Continuing Medical Education of Ministry of Health of China to provide continuing medical education for physicians. This education activity has been designated for 8 national category-1 CME Credits in China. Three hours of physician participation in CIT equals 1 credit. Documentation of awarded credit is provided for registered attendees in exchange for completed activity evaluations. Certificates of attendance are provided to all registered attendees. The following activities are not included in the official CIT CME program: luncheon workshops, luncheon symposia and interventional vascular simulation sessions.
Event Overview
Registration Not yet available Register Now
Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info
<strong>Program Sponsorship and Support </strong><br />The congress is sponsored by Chinese Medical Association, and National Center for Cardiovascular Diseases of China, and partially funded through educational grants from commercial supporters. The CIT strives to ensure that its programs are as educational as possible and free from bias. To support this endeavor, CIT director and co-directors create organizing and scientific committees to assist in educational content development and content oversight for live cases, concurrent sessions, case reviews, workshops, and scientific symposia. These sessions are developed without influence from commercial supporters.<br />
Exhibition Housing Info
<table align="right" border="0" cellpadding="0" cellspacing="0" class="cnz12" width="100%"><tbody><tr><td align="left" valign="middle">Welcome to exhibit at CIT2013! </td></tr><tr><td align="left" style="line-height:0;height:8px;" valign="top">&nbsp;</td></tr><tr><td align="left" valign="middle">Thank you for your continuous interest in participating in China Interventional Therapeutics (CIT) 2013. CIT2013 is the 11th annual scientific session of CIT. Over the past 10 years, CIT has witnessed itself to grow to be the most comprehensive and educational course in China and one of the best among Asian Pacific Region.</td></tr><tr><td align="left" style="line-height:0;height:8px;" valign="top">&nbsp;</td></tr><tr><td align="left" valign="middle">The meeting is attended by over 5000 delegates last year, including leading scientific experts and influential physicians in the field of interventional vascular diseases. The CIT Exhibit Hall provides a unique opportunity for members of industry to interact directly with attendees and exchange valuable information on the latest advancements and developments relative to treatment of cardiovascular and endovascular diseases.</td></tr><tr><td align="left" style="line-height:0;height:8px;" valign="top">&nbsp;</td></tr><tr><td>By attending the CIT Congress, our Interventional Cardiologists, Interventional Radiologists, Clinical Cardiologists, Electrophysiologists should be able to:</td></tr><tr><td align="left" valign="middle"><li style="list-style-type:disc;margin-left:15px;">Relate the results from important clinical trials and evidence-based medicine that guide the management of patients with atherosclerosis and structural heart disease</li><li style="list-style-type:disc;margin-left:15px;">Integrate new interventional techniques and procedures to the care of patients with complex coronary artery disease, peripheral vascular disease, and structural heart disease</li><li style="list-style-type:disc;margin-left:15px;">Integrate appropriate pharmacological management in the care of patients undergoing diagnostic angiography and interventional therapies before, during, and after catheterization</li><li style="list-style-type:disc;margin-left:15px;">Distinguish between new interventional technologies and propose their appropriate applications to patients with cardiovascular disease</li></td></tr><tr><td align="left" style="line-height:0;height:8px;" valign="top">&nbsp;</td></tr><tr><td align="left" valign="top">The following benefits are experienced by companies that exhibit at CIT and why over 80% of exhibitors return to CIT year after year:</td></tr><tr><td align="left" valign="top"><li style="list-style-type:disc;margin-left:15px;">Opportunities to interact with world-class thought leaders in the field of interventional vascular therapeutics.</li><li style="list-style-type:disc;margin-left:15px;">Opportunities to interact with an international attendee, as 15% of CIT attendees traveled from outside China.</li><li style="list-style-type:disc;margin-left:15px;">Exposure to a comprehensive educational program that covers all facets of interventional cardiology, including treatment for endovascular, structural, and coronary diseases.</li><li style="list-style-type:disc;margin-left:15px;">Information on latest breaking trial results delivered by lead investigators.</li></td></tr></tbody></table><br />
Thanos Boltsis , Afghanistan
Organising Agency
Event map
Revelant Events